Clinical trial
A Multi-center, Single-arm, Historically Controlled Pivotal Trial, to Assess the Safety and Effectiveness of Genex G as Part of the Surgical Treatment of Osteomyelitis of the Extremities.
NCT07270380 is registered in ClinicalTrials.gov with Biocomposites Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Single-arm, Historically Controlled Pivotal Trial, to Assess the Safety and Effectiveness of Genex G as Part of the Surgical Treatment of Osteomyelitis of the Extremities.
- Lead sponsor
- Biocomposites Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- October 31, 2028
- Enrollment
- 139 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.